Quest Diagnostics Q2 FY26 diluted EPS rises 15% to 2.84; revenue increases 10.2% to 3.04 billion

Reuters2026/07/23 10:47

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Quest Diagnostics posted Q2 net revenues of USD 3.04 billion, up 10.2% year over year, with reported diluted EPS of USD 2.84, up 15%.
Adjusted diluted EPS under non-GAAP climbed 19.1% to USD 3.12, while reported operating income rose 4.6% to USD 459 million.
Requisition volume increased 13.1%, while revenue per requisition fell 2.8%.
Highlights included double-digit Advanced Diagnostics growth, New York State approval for Haystack MRD, and a larger rollout of lab automation and IntelliDraw.
Full-year guidance was raised to net revenues of USD 11.95 billion-USD 12.05 billion, reported diluted EPS of USD 9.97-USD 10.17.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quest Diagnostics Incorporated published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607230645PR_NEWS_USPR_____NY10225) on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Quest Diagnostics Q2 FY26 diluted EPS rises 15% to 2.84; revenue increases 10.2% to 3.04 billion

You may also like

Crypto prices